These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 5677880)
21. [Urinary excretion of noradrenaline, adrenaline, normetanephrine and vanillylmandelic acid following myocardial infarct]. Jéquier E; Realini S; Izbicki M; Perret C Schweiz Med Wochenschr; 1968 Aug; 98(33):1216-8. PubMed ID: 5682095 [No Abstract] [Full Text] [Related]
22. [Trial of L-dopa as hypotensive medication in arterial hypertension. Preliminary report]. Torres Zamora M; García Monterd G; Chávez Domínguez R; Chávez Lara B; Serrano PA Arch Inst Cardiol Mex; 1974; 44(2):267-74. PubMed ID: 4599277 [No Abstract] [Full Text] [Related]
23. Diurnal blood pressure rhythm and urinary catecholamine excretion in obstructive sleep apnoea and essential hypertension. Lapiński M; Przybylowski T; Lewandowski J; Januszewicz A; Wocial B; Kowalski J; Droszcz W; Januszewicz W J Hypertens Suppl; 1993 Dec; 11(5):S292-3. PubMed ID: 8158391 [No Abstract] [Full Text] [Related]
24. [Catecholamines and corticosteroids in children with primary arterial hypertension]. Korenev NM; Rasin MS Kardiologiia; 1972 Sep; 12(9):63-7. PubMed ID: 4644956 [No Abstract] [Full Text] [Related]
25. [The influence of guanazodine and todralazine on blood pressure regulation during dynamic and static exercise in essential hypertension (author's transl)]. Reiterer W; Czitober H Arzneimittelforschung; 1977; 27(11):2163-7. PubMed ID: 580022 [No Abstract] [Full Text] [Related]
26. Adrenaline and noradrenaline excretion in placebo treated patients in the Medical Research Council Hypertension Trial and in matched normotensive controls. Brown MJ; Causon RC; Brennan P; Greenberg G J Hypertens Suppl; 1985 Dec; 3(3):S87-8. PubMed ID: 2856789 [TBL] [Abstract][Full Text] [Related]
27. [Animal experiment and clinical studies on the action mechanism of the antihypertensive agent guancydine]. Werning C; Vetter W; Schweikert HU; Armbruster H; Fischer N; Trübestein G; Siegenthaler W Verh Dtsch Ges Inn Med; 1971; 77():1004-8. PubMed ID: 5170618 [No Abstract] [Full Text] [Related]
28. [The effect of a psychoemotional load on the cardiovascular system and catecholamines in subjects with different levels of arterial pressure]. Kruchinina NA; Poroshin EE Fiziol Zh SSSR Im I M Sechenova; 1990 Jan; 76(1):33-40. PubMed ID: 2159911 [TBL] [Abstract][Full Text] [Related]
29. [Behavior of urinary catecholamines in hypertension]. Vivoli G; Bergomi M; Rovesti S; Caselgrandi E Cardiologia; 1988 Oct; 33(10):931-5. PubMed ID: 3233603 [No Abstract] [Full Text] [Related]
30. [Urinary excretion of noradrenaline, adrenaline and dopamine in patients with hypertension]. Marek J; Horký K; Kopecká J Sb Lek; 1973 Jan; 75(1):17-26. PubMed ID: 4683725 [No Abstract] [Full Text] [Related]
31. Effect of oral pyridoxine hydrochloride supplementation on arterial blood pressure in patients with essential hypertension. Aybak M; Sermet A; Ayyildiz MO; Karakilçik AZ Arzneimittelforschung; 1995 Dec; 45(12):1271-3. PubMed ID: 8595083 [TBL] [Abstract][Full Text] [Related]
32. Renal functional status and patterns of catecholamine excretion. Itskovitz HD; Wynn NC J Clin Hypertens; 1985 Sep; 1(3):223-7. PubMed ID: 3835235 [TBL] [Abstract][Full Text] [Related]
33. [Urinary excretion of adrenalin, noradrenalin and vanilmandelic acid in rats with experimental pneumococcal infection]. Guseva EV; Popenenkova AZ Biull Eksp Biol Med; 1969 Jun; 68(7):31-4. PubMed ID: 5397991 [No Abstract] [Full Text] [Related]